Clinical Trials Sponsored by ObsEva SA

Total 1020 results

ObsEva SA

Completed

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF (IMPLANT4)

Infertility

Belgium, Canada, Czechia, Denmark, Estonia, Germany, Hungary, Poland, Russian Federation, Spain
ObsEva SA

Completed

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids (PRIMROSE 1)

Uterine Fibroids | Heavy Menstrual Bleeding

United States
ObsEva SA

Terminated

A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth (TERM)

Preterm Labor

Poland, United Kingdom, Spain, Switzerland, Belgium, Germany
ObsEva SA

Completed

A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis (EDELWEISS)

Endometriosis

United States, Poland, Russian Federation, Ukraine
ObsEva SA

Completed

Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

Hepatic Impairment | Healthy Participants

United States
ObsEva SA

Completed

OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICSI (IMPLANT)

Infertility

Poland, United Kingdom, Spain, Belgium, Denmark, Czechia
ObsEva SA

Terminated

A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain

Endometriosis

United States, Canada, Puerto Rico
ObsEva SA

Completed

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids (PRIMROSE 2)

Uterine Fibroids | Heavy Menstrual Bleeding

United States, Bulgaria, Czechia, Hungary, Latvia, Lithuania, Poland, Romania, Ukraine
ObsEva SA

Completed

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Renal Impairment | Healthy Participants

United States
ObsEva SA

Completed

Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI (IMPLANT2)

Infertility

Belgium, Czechia, Denmark, Estonia, Finland, Germany, Hungary, Poland, Spain
ObsEva SA
Iqvia Pty Ltd; Cytel Inc.; Scope International AG; PhinC Development

Active, not recruiting

PoC Study of OBE022 in Threatened Preterm Labour (PROLONG)

Preterm Labor

Spain, Russian Federation, Vietnam, Czechia, Finland, Israel
Sankom SA
InterMedService SA; Pharmaxi LLC

Unknown

Study to Evaluate Impact SANKOM Patent Socks in Patients With CVI

Chronic Venous Insufficiency

Ukraine
Aptissen SA

Not yet recruiting

6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis

Osteoarthritis, Hip

France
Aktiia SA

Recruiting

Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation

Hypertension | Blood Pressure | Heart Rate

Switzerland
Firalis SA

Not yet recruiting

Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers

Healthy

France
Amazentis SA

Recruiting

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

Healthy | Healthy Aging | Healthy Diet

United States
Axalbion SA

Recruiting

A Study of Efficacy and Safety of AX-8 in Chronic Cough

Chronic Cough

United Kingdom
Cellaion SA

Active, not recruiting

Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF) (DHELIVER)

Acute on Chronic Liver Failure

Belgium, Spain, France, Austria, Denmark, Latvia, Germany, Bulgaria, Poland, Estonia, Italy, Lithuania, North Macedonia, Slovakia
Teoxane SA

Completed

RHA® 3 Versus Restylane-L® for Lip Augmentation

Lip | Lip Augmentation

United States
Maxivax SA

Active, not recruiting

MVX-ONCO-1 in Patients With Solid Tumor

Cancer | Solid Tumor

Switzerland
Poxel SA

Completed

Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)

NASH - Nonalcoholic Steatohepatitis

United States
Anokion SA

Active, not recruiting

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis (MoveS-it)

Relapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)

United States
Amazentis SA

Completed

Detection of Gut Metabolites in Mother's Milk Following Juice Intake

Healthy Diet

United States
Phargentis SA

Completed

Bioequivalence Study of Tiotropium Bromide Inhalation Powder

COPD

United States, India, Switzerland
Teoxane SA

Completed

RHA® 4 NLF Cannula

Aging | Wrinkle | Nasolabial Fold

United States
Cryotherapeutics SA

Withdrawn

Pilot Study on the Effect of Intracoronary Cryotherapy on Stabilization of Vulnerable Plaque at Risk of Rupture (ICEBERG)

Acute Coronary Syndrome

Denmark, Sweden
Abionic SA

Completed

Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.

Sepsis | Sepsis Bacterial

France
Stalicla SA

Completed

Characterization of a Clinical Subpopulation With Autism Spectrum Disorder

Autism Spectrum Disorder

United States
Stalicla SA

Withdrawn

Characterization of a Clinical Subpopulation in Children With Autism Spectrum Disorder

Autism Spectrum Disorder

United States
Sintetica SA

Completed

Efficacy, Safety and Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

Healthy Volunteers

Austria
Stalicla SA

Completed

Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder

Autism Spectrum Disorder

United States
Sintetica SA

Completed

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

Healthy Subjects

Switzerland
Firalis SA

Active, not recruiting

HeartLinc, a Study With AMI Patients Undergoing PCI (HeartLinc)

AMI Patients

France, Korea, Republic of
Spineart SA

Terminated

ROMEO®2 PAD. 2 YEARS PROSPECTIVE FOLLOW-UP (ROMEO 2 PAD FR)

Spinal Disease

France
Anecova SA

Completed

Endometrial Fluid Study in Natural Cycles: a Prospective Observational Study

Endometrial Fluid

Spain
Pharnext SA

Completed

Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)

Charcot-Marie-Tooth Disease Type 1A

United States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany
Combioxin SA

Completed

Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae

Pneumonia | Pneumococcal Infections

France, Belgium
PregLem SA

Completed

PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIV)

Uterine Fibroids

United Kingdom, Belgium, Czechia, France, Germany, Hungary, Italy, Latvia, Lithuania, Romania, Ukraine
Abionic SA

Completed

Early Diagnostic of Sepsis and Potential Impact on Antibiotic Management Based on Serial.Pancreatic Stone Protein (PSP) Measured Using the AbioScope.

Sepsis

France, Italy, Switzerland, United Kingdom
Anecova SA

Terminated

Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy?

Infertility | Reproductive Sterility

Spain
Anecova SA

Withdrawn

Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the Performance of the Anecova Intra Uterine Culture Device

Infertility | Reproductive Sterility

Spain
Poxel SA

Completed

Effect of Cimetidine on the PK of Imeglimin

Healthy

United Kingdom
Him SA

Unknown

Multi-level Integration for Patients With Complex Needs Facilitated by ICTs. A Shared Approach, Mutual Learning and Evaluation Are Expected to Create Synergies Among the Partners and to Bring Forward Integration of Care in Europe (CAREWELL)

Diabetes | Chronic Obstructive Pulmonary Disease | Frail Elderly Syndrome | Chronic Heart Failure

Croatia, Italy, Poland, Spain, United Kingdom
Sensoptic SA

Completed

Objective Measurement of Ossicular Chain Mobility Using a Palpating Instrument Intraoperatively (PalpEar)

Otosclerosis of Middle Ear | Cholesteatoma, Middle Ear | Disorder of Middle Ear
Poxel SA

Completed

A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Latvia
Cytheris SA

Terminated

Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders (Inspire 3)

HIV

Switzerland, Italy, South Africa
PregLem SA

Completed

PGL4001 Versus Placebo in Uterine Myomas (PEARLI)

Uterine Myomas

Czech Republic, Hungary, India, Romania, Russian Federation, Ukraine
Cytheris SA

Unknown

Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients (CONVERT)

Chronic Hepatitis B

France, Italy
Cytheris SA

Completed

Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1) (ECLIPSE 1)

Hepatitis C

France, Switzerland, Italy
Phytotox SA

Withdrawn

Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles

Facial Wrinkles

Argentina

3

Subscribe